-transparent.png){kind=logo}
Cystic lymphatic malformations are haemodynamically inactive vascular malformations that never regress. During a nine-year period, 52 patients with cervico-facial superficial cystic lymphatic malformations underwent percutaneous sclerotherapy with Ethibloc (a corn-based alcohol derivative). In 57 percent (30/52) of cases, the outcome of sclerotherapy alone was excellent or good: in 19 percent (10/52), the procedure had to be combined with surgery for aesthetic reasons; and in the remaining 24 percent (12/52), the treatment failed. The results suggest percutaneous sclerotherapy with Ethibloc to be safe and effective, and that it is to be recommended as the treatment of choice in cases of superficial cystic lymphatic malformations.
M Tovi, and
D Herbreteau, and
O Enjolras, and
J J Merland
November 2006,
Plastic and reconstructive surgery,
M Tovi, and
D Herbreteau, and
O Enjolras, and
J J Merland
January 2008,
Lymphatic research and biology,
M Tovi, and
D Herbreteau, and
O Enjolras, and
J J Merland
January 2011,
Indian journal of dermatology, venereology and leprology,
M Tovi, and
D Herbreteau, and
O Enjolras, and
J J Merland
September 2017,
Journal of vascular surgery. Venous and lymphatic disorders,
M Tovi, and
D Herbreteau, and
O Enjolras, and
J J Merland
September 2023,
Journal of neurointerventional surgery,
M Tovi, and
D Herbreteau, and
O Enjolras, and
J J Merland
February 2019,
Orbit (Amsterdam, Netherlands),
M Tovi, and
D Herbreteau, and
O Enjolras, and
J J Merland
July 2014,
Annals of vascular surgery,
M Tovi, and
D Herbreteau, and
O Enjolras, and
J J Merland
November 2014,
Journal of neurointerventional surgery,
M Tovi, and
D Herbreteau, and
O Enjolras, and
J J Merland
January 2016,
Surgery today,
M Tovi, and
D Herbreteau, and
O Enjolras, and
J J Merland
October 2011,
Journal of vascular and interventional radiology : JVIR,
